[Management of restless legs syndrome]

Area of Science:

• Neurology
• Sleep Medicine

Context:

• Restless Legs Syndrome (RLS) significantly impacts patient quality of life.
• Management requires addressing potential contributing factors like iron deficiency and certain medications.

Purpose:

• To outline current management strategies for Restless Legs Syndrome.
• To detail pharmacological treatments and their appropriate application.

Summary:

• Initial RLS management focuses on identifying and treating causative factors and promoting healthy sleep hygiene.
• Pharmacological treatment is reserved for clinically significant RLS, with dopaminergic agents as first-line therapy.
• Key drug classes include dopaminergic agents, antiepileptics, opioids, and benzodiazepines, with ropinirole and pramipexole specifically licensed in France.
• Regular patient follow-up is crucial for assessing treatment effectiveness, managing side effects, and detecting augmentation.

Impact:

• Provides a framework for clinicians managing RLS patients.
• Highlights the importance of individualized treatment plans and vigilant monitoring for adverse effects.
• Addresses specific considerations for RLS in comorbid conditions like renal insufficiency, pregnancy, and pediatric cases.